The Elizabeth H. and James S. McDonnell III Genome Institute provides comprehensive genomic services to Washington University and the scientific community.
Leading the way in high-speed, comprehensive genomics.
We aim to improve the human condition by producing, studying and interpreting high-quality genome-based data that drives biological discoveries.
A Team of Experts
Li Ding, PhD, led a team that analyzed DNA from nearly 10,000 patient tumors across 33 cancer types. They found 300 genes that drive cancer, and more than half of the tumors analyzed had at least one mutation of clinical significance.
Over $1.3B in Research Funding
The McDonnell Genome Institute has received over $1.3 billion in research funding to inform future clinical work and help in the study, diagnosis and treatment of disease.
Latest News
Immune responses to tuberculosis mapped across 3 species
A detailed genetic road map will guide research into TB treatments, vaccines. This work and article features co-senior author Makedonka Mitreva, PhD, a professor of medicine and of genetics at Washington University and a researcher at the university’s McDonnell Genome Institute.
$3.7M Grant Supports Precision Medicine, Genomics Database
Washington University has received a grant from NIH that will support an open-source genomic database to advance precision medicine for cancer.
Kingdom Capital Collaborates with Washington University School of Medicine to Launch Augmented Intelligence Company PercayAI
- PercayAI, launched by Kingdom Capital, represents the investment firm's commitment to cultivating new technologies that can help accelerate drug discovery and improve patient outcomes - Washington University School of Medicine in St. Louis will continue to develop technology that will be commercialized through PercayAI as part of an ongoing collaboration with Kingdom Capital
